Biomarkers of Infection-Associated Cancers (R21)
Document Type: Grants Notice
Funding Opportunity Number: PA-08-157
Opportunity Category: Discretionary
Posted Date: Apr 22, 2008
Creation Date: Apr 22, 2008
Original Closing Date for Applications: May 07, 2011
Current Closing Date for Applications: May 07, 2011
Archive Date: Jun 07, 2011
Funding Instrument Type: Grant
Category of Funding Activity:
Category Explanation:
Award Ceiling: $200.000
CFDA Number: 93.121 -- Oral Diseases and Disorders Research
CFDA Number: 93.393 -- Cancer Cause and Prevention Research
CFDA Number: 93.394 -- Cancer Detection and Diagnosis Research
CFDA Number: 93.396 -- Cancer Biology Research
Cost Sharing or Matching Requirement: No
Description:
-Purpose. . This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI) and the National Institute of Dental and Craniofacial Research (NIDCR), of the National Institutes of Health (NIH), encourages the submission of Research Project Grant (R01) applications from institutions and organizations that propose to identify biomarkers for cancers where the etiology of the disease is attributed to infectious agents. -Mechanism of Support. This FOA utilizes the NIH Exploratory/Developmental Grant (R21) mechanism and runs in parallel with an FOA of identical scientific scope, PA-08-156, that solicits applications under the NIH Research Project Grant (R01) mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications; therefore, the anticipated number of awards is not known. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
Full Announcement.
|